Sep 8, 2025 | Claims, High-cost claims, Stop-Loss
Stop-loss coverage is no longer just a safeguard – it’s essential for protecting your plan against escalating financial risk. Between 2013 and 2024, the frequency of claims exceeding $2 million grew by more than 1,250%, underscoring why having strong protection in...
Aug 12, 2025 | Cancer, Chronic conditions, Heart disease, MedBen WellLiving, Preventive Care, Stop-Loss, Wellness, Wellness exam, Wellness screenings
In its 2025 High-Cost Claims and Injectable Drug Trend Analysis, Sun Life highlights a familiar but costly trend: malignant neoplasm (cancer) and cardiovascular disease continue to rank among the top drivers of stop-loss claim reimbursements. These chronic conditions...
Apr 22, 2025 | Compliance, Genomics, MedBen University, Mental health parity, Roundtables, Stop-Loss, Wellness
Nearly 50 clients and brokers attended the MedBen University (MBU) 2025 Employer Roundtable on April 9. Industry professionals from MedBen, Sun Life, and Profero Team provided attendees with outside-the-box ways to blend benefits management and employee well-being,...
Feb 11, 2025 | Benefits Advisory Conference, Benefits management, Caroline Fraker, Compliance, Forensic claims review, MedBen University, No Surprises Act (NSA), Pharmacy, Stop-Loss, Wellness
Over 70 guests from seven states attended the MedBen 2025 Benefits Advisory Conference on January 30. Featuring some of the most respected names in the industry, this invitation-only event provided brokers with an extensive look at the state of benefits...
Jul 9, 2024 | Cancer, Claims, Client Report, Heart, Heart disease, High-cost claims, MedBen WellLiving, Preventive Care, Stop-Loss, Wellness, Wellness exam, Wellness screenings
Cardiovascular disease (CVD) has risen to second place on the list of top stop-loss reimbursements, according to Sun Life’s annual report of high-cost claims – the first time the condition has ranked so high. As in past years, the report underlines the...
Feb 6, 2024 | Claims, Claims data, Cost Savings, Drug costs, Gene therapy, Genetic testing, MedBen News, MedBen Rx, MedBen University, Pharmacogenics, Pharmacy Benefits Manager (PBM), Self-funding, Specialty Drugs, Stop-Loss
MedBen recently had the honor to welcome some of the most respected names in the benefits management industry. At the invitation-only 2024 Benefits Advisory Conference on January 26, attending brokers learned about health plan innovations that will help self-funded...
